Premium
O213: Daclatasvir vs telaprevir in combination with peginterferon alfa/ribavirin in treatment‐naive patients with HCV genotype 1: phase 3 COMMAND‐3 results
Author(s) -
Ira M. Jacobson,
Stefan Zeuzem,
Robert Flisiak,
Brygida Knysz,
Stefan Lueth,
Dorota ZarębskaMichaluk,
Ewa Janczewska,
Péter Ferenci,
M. Diago,
A.L. Zignego,
Rifaat Safadi,
Yaacov Baruch,
Dzhamal Abdurakhmanov,
Stephen D. Shafran,
D. Thabut,
Rafael Bruck,
Adrián Gadano,
Alexander Thompson,
Justin Kopit,
Fiona McPhee,
Tracy Michener,
Eric Hughes,
Ping Yin,
Stephanie Noviello
Publication year - 2014
Publication title -
journal of viral hepatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.12332_8
Subject(s) - telaprevir , daclatasvir , ribavirin , medicine , virology , genotype , gastroenterology , chronic hepatitis , biology , genetics , gene , virus